Repository logo

The efficacy of ProgestoNat cream in the treatment of menopausal syndrome

dc.contributor.authorMcTeer, Tarynen_US
dc.date.accessioned2007-10-17T12:49:50Z
dc.date.available2007-10-17T12:49:50Z
dc.date.issued2003
dc.descriptionThesis (Masters in Technology: Homoeopathy), Durban Institute of Technology, Durban, South Africa, 2003en_US
dc.description.abstractThis double blind, randomised, placebo controlled study investigated the efficacy of ProgestoNat® cream in the treatment of menopausal syndrome in terms of subjective and objective data. Menopause is defined as that point in time when permanent cessation of menstruation occurs following the loss of ovarian follicular activity. The perimenopause is the period just prior to the final menstrual period and is associated with the development of typical oestrogen deficiency symptoms such as hot flushes, night sweats, mood swings and loss of libido, to mention a few. The most widely used treatment for these symptoms is hormone replacement therapy. This form of treatment is effective for many women, but there are many risks and side effects associated with its use and there is a growing demand for natural alternatives, like natural progesterone creams. It is for this reason that the efficacy of ProgestoNat® cream was investigated as a natural alternative to hormone replacement therapy.en_US
dc.description.levelMen_US
dc.format.extent86 pen_US
dc.identifier.doihttps://doi.org/10.51415/10321/71
dc.identifier.otherDIT102816
dc.identifier.urihttps://hdl.handle.net/10321/71
dc.language.isoenen_US
dc.subjectHomoeopathyen_US
dc.subject.lcshHomoeopathy--Dissertations, Academicen_US
dc.subject.lcshMenopauseen_US
dc.titleThe efficacy of ProgestoNat cream in the treatment of menopausal syndromeen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
McTeer_2003.pdf
Size:
619.28 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Item-specific license agreed upon to submission
Description: